Atrial fibrillation is a well-known risk factor for stroke that often remains undetected; yet, the benefit of screening of asymptomatic individuals remains unclear. A recent randomized trial ...

Oxford University-led AMALFI clinical trial results presented at the European Society of Cardiology (ESC) Congress 2025 and published in the Journal of the American Medical Association (JAMA). AMALFI ...

Madrid, Spain – 29 August 2025: A mail-based atrial fibrillation (AF) screening programme with ECG-patch monitoring led to a modest long-term increase in AF diagnosis and anticoagulation exposure in ...

That's a potential message from a randomized trial that tested an AF screening strategy relying on an implantable loop recorder (ILR) in older adults without AF but with other stroke risk factors who ...

Continuous ECG monitoring with an implantable loop recorder detected more cases of asymptomatic atrial fibrillation, but did not reduce the risk of stroke or improve overall survival, according to a ...

Atrial fibrillation (AF), a condition characterized by abnormal, fast heart beats, affects an estimated five million people in the U.S alone. If it goes undiagnosed, AF can lead to a number of health ...

Screening individuals for atrial fibrillation (AF) using wearable devices is more cost-effective than screening using conventional methods such as 12-lead electrocardiogram (ECG) and pulse palpation, ...

Experts note that implantable loop recorders are valuable for detecting infrequent arrhythmias and guiding anticoagulation decisions post-cryptogenic stroke or atrial fibrillation ablation, but due to ...

They say the surest path to a person’s heart is through their stomach, but according to MindMics, it might actually be through the ears. The Massachusetts-based startup’s technology uses in-ear ...

The global left atrial appendage closure (LAAC) devices market is expected to witness substantial growth and is projected to expand at a CAGR of nearly 15% over the next five years. The increasing ...